Skip to main content
. 2022 Jun 8;12:807264. doi: 10.3389/fonc.2022.807264

Table 3.

Univariate and multivariate logistic regression analyses.

(a) Univariate logistic regression Testing Set External Validation Set
P value Exp (B) (95% CI) P value Exp (B) (95% CI)
Sex 0.316 1.6 (0.638, 4.011) 0.051 0.393 (0.153, 1.006)
Age 0.051 2.679 (0.995, 7.212) 0.042 2.768 (1.039, 7.376)
TNM stage 0.822 1.138 (0.369, 3.513) 0.998 0 (0, -)
CEA 0.033 2.796 (1.087, 7.197) 0.029 3.667 (1.145, 11.74)
CA-199 0.087 2.128 (0.896, 5.055) 0.054 2.505 (0.985, 6.37)
CRP 0.198 2.348 (0.639, 8.621)
LDH 0.999 5.80e8 (0, -) 0.207 2.4 (0.617, 9.339)
Lymphocytes 0.24 2.186 (0.593, 8.062) 0.133 2.2 (0.788, 6.146)
Neutrophils 0.414 1.524 (0.555, 4.186) 0.097 2.508 (0.846, 7.436)
NLR 0.142 3.155 (0.681, 14.623) 0.04 3.045 (1.054, 8.804)
Patch-indi 0.06 2.248 (0.967, 5.224) 0.219 1.786 (0.709, 4.5)
Patch-comb 0.053 2.548 (0.989, 6.564) 0.023 3.143 (1.171, 8.437)
DeepPCR 0.0001 6.125 (2.462, 15.239) 0.0001 7 (2.575, 19.028)
(b) Multivariate logistic regression Test Cohort External Validation Cohort
Sig. Exp (B) (95% CI) Sig. Exp (B) (95% CI)
Sex 0.143 2.45 (0.739, 8.124) 0.011 0.122 (0.024, 0.621)
Age 0.489 1.576 (0.434, 5.72) 0.705 1.346 (0.289, 6.261)
TNM stage 0.965 1.034 (0.233, 4.582) 0.998 0 (0, -)
CEA 0.101 2.718 (0.823, 8.973) 0.189 3.211 (0.564, 18.284)
CA-199 0.124 2.413 (0.785, 7.415) 0.059 4.137 (0.945, 18.108)
CRP 0.104 4.607 (0.732, 29.003)
LDH 0.999 2.6e8 (0, -) 0.118 7.334 (0.604, 89.051)
Lymphocytes 0.128 3.412 (0.704, 16.539) 0.203 3.418 (0.514, 22.723)
Neutrophils 0.979 0.981 (0.239, 4.023) 0.874 0.846 (0.107, 6.699)
NLR 0.138 4.242 (0.628, 28.678) 0.05 8.854 (0.995, 78.749)
Patch-indi 0.346 1.657 (0.58, 4.732) 0.831 0.855 (0.204, 3.591)
Patch-comb 0.8 0.819 (0.175, 3.842) 0.642 1.453 (0.301, 7.023)
DeepPCR 0.008 6.879 (1.646, 28.743) 0.004 10.461 (2.138, 51.186)

(a) Univariate logistic regression analysis of the testing set and external validation set. (b) Multivariate logistic regression analysis of the testing set and external validation set. The covariates were sex, age, TNM stage, CEA, CA19-9, CRP, LDH, lymphocytes, neutrophils, neutrophil-to-lymphocyte ratio (NLR), patch-based individual (patch-indi) model, patch-based combined (patch-comb) model, and DeepPCR model.